PPARG and metabolic dysfunction-associated steatotic liver disease: Peroxisome proliferator-activated receptors (PPARs) are crucial in the pathogenesis of non-alcoholic fatty liver disease (NAFLD), PPARα primarily enhances fatty acid oxidation in the liver, while PPARG (PPARγ) facilitates lipid transport [78].